Filipp G
Allergol Immunopathol (Madr). 1976 Jan-Feb;4(1):15-28.
The wide mosaic of congruent clinical and experimental observations led to the postulation that the cause of the pharmacological abnormality of the asthmatic patient, i.e. the immensely increased reactivity of the bronchial smooth muscles, is to be sought in an insufficiency of the beta-adrenergic receptor system. It is to be assumed that the so-called asthma diatheses is based inter alia on a genetically determined defect of the adenyl cyclase system. The role of previous infections of the respiratory tract in asthmagenesis should lie--following this working theory--not in a sensitization in the sense of an allergic reaction of the immediate type, but in the formation of a defective beta-adrenergic substance or in a blockade of the beta-receptor. A genetically determined innate defect of the beta-adrenergic receptors, or a defect acquired through infections of the respiratory tract, is hence likely to be the cause of the pathologically potentiated reactivity of the bronchia. It is likely that the infective stimuli--quite apart from this preparatory role--are later capable of triggering asthmatic paroxysms when the vegetative homeostasis is impaired. We know from the experiments of many authors that a blockade of the beta-receptors produced by chemical blocker substances, or by pertussis vaccine or various bacterial substances, results in a significant increase in bronchial reactivity towards histamine, serotonin, acetylcholine and other stimuli. We have shown in our experiments that heat-inactivated adeno viruses and influenza viruses also increase the anaphylactic shock reactivity and the histamine reactivity of the organism. On the basis of this working hypothesis, the pathomechanism of the asthmatic process is as follows in individual asthma forms: 1) In the 'purely" allergic asthma form, the antigen-antibody reaction that occurs after sensitization (i.e. formation of skin-sensitizing allergic antibodies of the class IgE) results in re-formation and release of slow-reacting-substances.
spasm of the bronchial muscles, asthmatic paroxysm. The expulsion of catecholamines that follows the release of slow-reacting-substances makes a decisive contribution to the reestablishment of the impaired homeostatic balance. It is to be assumed that this form of asthma both symptomatically and causally--using specific desensitization--can be influenced more easily than other forms of asthma with a more complicated pathogenic background. 2) In the second allergically determined form of asthma, we are confronted by the genetically fixed or acquired insufficiency of the beta-receptors in addition to the immunological mechanism. As a result of the innate or acquired blockade of the beta-receptive substance, or the relative dominance of the alpha-receptors, the catecholamines (that physiologically serve to maintain homeostasis) contribute to a protraction, intensification and perpetuation of the bronchial obstruction. In this way the asthmatic circulus vitiosus is complete...
大量一致的临床和实验观察结果促使人们推测,哮喘患者药理学异常的原因,即支气管平滑肌反应性极度增加,应归因于β-肾上腺素能受体系统功能不足。可以假定,所谓的哮喘素质尤其基于腺苷酸环化酶系统的遗传决定缺陷。按照这一工作理论,既往呼吸道感染在哮喘发病中的作用不应在于速发型过敏反应意义上的致敏,而在于形成有缺陷的β-肾上腺素能物质或阻断β-受体。因此,β-肾上腺素能受体的遗传决定先天性缺陷或因呼吸道感染获得的缺陷很可能是支气管病理性增强反应性的原因。很可能感染性刺激——除了这种预备作用之外——在植物性稳态受损时,以后能够引发哮喘发作。我们从许多作者的实验中得知,化学阻断剂物质、百日咳疫苗或各种细菌物质产生的β-受体阻断会导致支气管对组胺、5-羟色胺、乙酰胆碱和其他刺激的反应性显著增加。我们在实验中表明,热灭活腺病毒和流感病毒也会增加机体的过敏性休克反应性和组胺反应性。基于这一工作假设,个体哮喘形式中哮喘过程的发病机制如下:1)在“纯粹”过敏性哮喘形式中,致敏后发生的抗原-抗体反应(即IgE类皮肤致敏性过敏抗体的形成)导致慢反应物质的重新形成和释放。
支气管肌肉痉挛,哮喘发作。慢反应物质释放后儿茶酚胺的排出对受损稳态平衡的重建起决定性作用。可以假定,这种形式的哮喘在症状和病因方面——采用特异性脱敏——比其他具有更复杂致病背景的哮喘形式更容易受到影响。2)在第二种由过敏决定的哮喘形式中,除了免疫机制外,我们还面临β-受体的遗传固定或获得性不足。由于β-受体物质的先天性或获得性阻断,或α-受体的相对优势,儿茶酚胺(生理上用于维持稳态)导致支气管阻塞的延长、加剧和持续。这样,哮喘恶性循环就完成了……